insights_auto
Why is ZLDPF up ၄.၉၉%?
Dive Deeperchevron_right
ZLDPF:OTCMKTS
Zealand Pharma A/S
၄၀.၀၀ US$
arrow_upward
+၄.၉၉%(+၁.၉၀) 1D
အောက် ၂, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZLDPF...
Open
၃၆.၈၀ US$
High
၄၀.၀၀ US$
Low
၃၆.၈၀ US$
Mkt. cap
၂၇၄.၁၂ ဋေ
Avg. vol.
၇၀၅.၀၀
Volume
၂.၁၀ ထောင်
52-wk high
၈၃.၁၂ US$
52-wk low
၃၅.၉၃ US$
Beta
၁.၂၃
Shares outstanding
၇.၁၆ ကုဋေ
No. of employees
၅၇၈
Open
၃၆.၈၀ US$
High
၄၀.၀၀ US$
Low
၃၆.၈၀ US$
Mkt. cap
၂၇၄.၁၂ ဋေ
Avg. vol.
၇၀၅.၀၀
Volume
၂.၁၀ ထောင်
52-wk high
၈၃.၁၂ US$
52-wk low
၃၅.၉၃ US$
Beta
၁.၂၃
Shares outstanding
၇.၁၆ ကုဋေ
No. of employees
၅၇၈
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Premarket movers: Alphabet rises on new AI model, Zealand Pharma sinks
Investing.com Australia
·
ပြီးခဲ့သည့် ၁ ရက်
Zealand Pharma shares fall 12% after obesity drug trial flags side effects
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S